Cat. No. |
Product Name |
Information |
PC-72636 |
CXCR7 modulator 18
CXCR7 modulator
|
CXCR7 modulator 18 is a novel potent, selective CXCR7 modulator with Ki of 13 nM, β-arrestin EC50 of 11 nM. |
PC-72635 |
CXCR7 modulator 20
CXCR7 modulator
|
CXCR7 modulator 20 is a small molecule modulator of the atypical chemokine receptor CXCR7 with Ki of 52 nM. |
PC-72634 |
ACT-1004-1239
CXCR7 antagonist
|
ACT-1004-1239 is a potent, selective, orally available CXCR7 antagonist with IC50 of 3.2 nM (hCXCR7). |
PC-72032 |
HF50731
CXCR4 antagonist
|
HF50731 (HF-50731) is a novel potent, selective CXCR4 antagonist with Ki of 19.8 nM in the CXCR4 competitive binding assay. |
PC-38130 |
ML339
CXCR6 antagonist
|
ML 339 is a potent and selective hCXCR6 antagonist (IC50 = 140 nM), 100-fold less active at the murine CXCR6 receptor (IC50 = 18 uM). |
PC-38129 |
CXCR6 inhibitor 81
CXCR6 inhibitor
|
CXCR6 inhibitor 81 is a potent (EC50=40 nM) and selective orally bioavailable small molecule antagonist of human CXCR6 receptor. |
PC-35940 |
CCR1 inhibitor 19e
CCR1 inhibitor
|
CCR1 inhibitor 19e is a novel potent, selective CCR1 antagonist with IC50 of 6.8 nM, inhibits CCR1chemotaxis in THP-1 cells with IC50 of 28 nM.. |
PC-35854 |
BI-9667
CCR1 inhibitor
|
BI-9667 (BI9667) is a potent, selective CCR1 antagonist.. |
PC-35832 |
CCX-354
CCR1 inhibitor
|
CCX-354 (GSK-2941266, CCX354-C, CCX354) is a potent, selective, orally-available CCR1 antagonist for the treatment of inflammatory diseases such as rheumatoid arthritis (RA). |
PC-35600 |
LIT-927
|
LIT-927 (LIT927) is the first selective, locally and orally active CXCL12 neutraligand with Ki of 267 nM for CXCL12-TR binding inhibition. |
PC-35572 |
CCR6 inhibitor 35
CCR6 inhibitor
|
CCR6 inhibitor 35 is a potent and selective CCR6 inhibitor with IC50 of 6.0 nM (hCCR6). |
PC-35514 |
AZ084
CCR8 inhibitor
|
AZ084 (AZ-084) is a potent, selective, allosteric, orally available CCR8 antagonist with Ki of 0.9 nM. |